Catherine Bovenizer

Catherine Bovenizer discloses dealings in Seelos Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 15 March 2016 and the latest from 20 May 2016.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 20 May 2016 with a share grant in Seelos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.